Coeptis Therapeutics Inc.
Pharmaceutical company · Wexford, Pennsylvania, United States
Coeptis Therapeutics Inc. is a pharmaceutical company headquartered in Wexford, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Coeptis Therapeutics at a glance
Typepharmaceutical company
HeadquartersWexford, Pennsylvania, United States
SEC industryPharmaceutical Preparations
SEC CIK1819663
What does Coeptis Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $5.5 million sold (2021).
Frequently asked questions about Coeptis Therapeutics
Where is Coeptis Therapeutics headquartered?
Coeptis Therapeutics Inc. is headquartered in Wexford, Pennsylvania, United States.
What does Coeptis Therapeutics do?
Coeptis Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Coeptis Therapeutics Holdings, Inc.Wexford, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences